|
Description:
The study will compare an investigational oral medicine and placebo in patients with type 2 diabetes and increased cardiovascular risk. All study-related medical care and study medicine are provided at no cost, and we will compensate you for time and travel.
What is expected of me?
This study requires approximately 22 clinic visits over the course of the study.
There are 10 visits during the first year, with additional follow-up visits
every 14 weeks thereafter.
Who qualifies for the study?:
Men and women, age 18 years and older, with documented type 2 diabetes and increased cardiovascular risk defined as prior history of one of the following: heart attack, coronary disease with surgical intervention, unstable angina (chest pain), stroke, or peripheral artery disease.
Glycohemoglobin (A1c) greater than 7.0%.
Stable doses of diabetes medications for at least 12 weeks prior to enrollment.
Women who are able to become pregnant must agree to use birth control.
You may not be in the study if you:
Significant liver or kidney disease; bariatric (or gastrointestinal) surgery; cancer within the past 5 years (except basal cell skin cancers); treatment with weight loss medications; women who are nursing or pregnant; alcohol or drug abuse.
Length of Study:
Up to 4 years
Study Location:
Investigator Information:
Karl Saxman, MD, Kathryn Gilliland, MD, Diane M. Kimball, ARNP
To obtain more information about this study please contact:
541-242-4343
Back to Clinical Research |
